Emergen Research Logo The global Generic Drug Market size was USD 360.84 Billion in 2022 and is expected to register a rapid revenue CAGR o ...
Four people have been charged in the death of a 5-year-old boy who was killed inside a pressurized oxygen chamber at a ...
Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC that the market rally that ...
Josh Brown, CEO of Ritholtz Wealth Management, said during a program on CNBC last month that he’s paying attention to Gilead Sciences Inc (NASDAQ:GILD).
I think of transformation as a pretty big word, like ‘Everything is different,’ said Baptist Health's Dr. Brett Oliver ...
According to the latest information released by the Fungicide Resistance Action Committee (FRAC), over 30 fungicide selective targets have been identified and acknowledged in the field of fungicide ...
Here's your ultimate Daredevil Season 1 recap, with everything you need to remember about the start of Matt Murdock and Wilson Fisk's battle.
Vishwambhara was announced as Mega 156 on August 22, 2023. The film was officially launched with a pooja ceremony on October ...
El-Pukinson’s story is one of imagination, passion, and an unwavering pursuit of greatness. Born Puki Dauda Mohammed in ...
While the media mogul spent more than half a century building up back-door political influence, the social media broligarch stormed into the US Government in just two years. Peter Jukes explores how t ...
Tv Therapeutics (NASDAQ:VTVT) said on Monday that the U.S. FDA has lifted the clinical hold on cadisegliatin's clinical trial ...
5d
GlobalData on MSNAtsena’s ATSN-201 gains FDA fast track status for XLRS treatmentThe Phase I/II LIGHTHOUSE trial is assessing the safety and tolerability of the gene therapy in male subjects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results